Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Sci Adv ; 7(49): eabj5830, 2021 Dec 03.
Article in English | MEDLINE | ID: mdl-34851674

ABSTRACT

B cells are an adaptive immune target of biomaterials development in vaccine research but, despite their role in wound healing, have not been extensively studied in regenerative medicine. To probe the role of B cells in biomaterial scaffold response, we evaluated the B cell response to biomaterial materials implanted in a muscle wound using a biological extracellular matrix (ECM), as a reference for a naturally derived material, and synthetic polyester polycaprolactone (PCL), as a reference for a synthetic material. In the local muscle tissue, small numbers of B cells are present in response to tissue injury and biomaterial implantation. The ECM materials induced mature B cells in lymph nodes and antigen presentation in the spleen. The synthetic PCL implants resulted in prolonged B cell presence in the wound and induced an antigen-presenting phenotype. In summary, the adaptive B cell immune response to biomaterial induces local, regional, and systemic immunological changes.

2.
Laryngoscope ; 130(4): 955-960, 2020 04.
Article in English | MEDLINE | ID: mdl-31283030

ABSTRACT

OBJECTIVES: In the larynx, differentiating squamous papillomas from de-novo papillary squamous dysplasias or squamous cell carcinomas (SCC) has significant consequences for management. Overlapping clinical presentations and cytologic changes across the spectrum of papillary lesions presents diagnostic challenges for otolaryngologists and pathologists. In this study, we evaluate whether ribonucleic acid (RNA) in-situ hybridization (ISH) for low-risk and high-risk human papillomavirus (HPV) can help distinguish these lesions. METHODS: We constructed tissue microarrays from 97 papillary laryngeal lesions, including 61 squamous papillomas, two papillomas with dysplasia, two SCCs-ex papilloma, 14 papillary squamous dysplasias, and 18 papillary SCCs identified at the Johns Hopkins Hospital between 2000 and 2017. We performed RNA ISH using probes for low-risk and high-risk HPV types. RESULTS: Low-risk HPV RNA was identified in 55 benign papillomas (90%), two papillomas with dysplasia (100%), and two SCCs-ex papilloma (100%) but was absent in de-novo papillary dysplasias and SCCs (0%). High-risk HPV RNA ISH was positive only in four papillary SCC (22%). Overall, low-risk HPV RNA ISH was 90% sensitive and 89% specific for benign papillomas with a positive predictive value of 93% and negative predictive value of 84%. In contrast, high-risk HPV was 20% sensitive for SCC. CONCLUSION: Low-risk HPV RNA ISH is a useful diagnostic adjunct for distinguishing laryngeal squamous papillomas from papillary squamous dysplasia and SCC. However, it is not entirely specific for benign processes as it is also retained in papillomas with dysplasia and SCCs-ex papilloma. Because high-risk HPV is rare in papillary laryngeal lesions, high-risk HPV RNA ISH has limited utility. LEVEL OF EVIDENCE: Level 4 Laryngoscope, 130:955-960, 2020.


Subject(s)
Carcinoma, Squamous Cell/diagnosis , DNA, Viral/genetics , Laryngeal Neoplasms/diagnosis , Larynx/pathology , Neoplasm Staging/methods , Papillomaviridae/genetics , Papillomavirus Infections/diagnosis , Biopsy , Carcinoma, Squamous Cell/virology , Diagnosis, Differential , Female , Follow-Up Studies , Humans , In Situ Hybridization , Laryngeal Neoplasms/virology , Male , Papilloma/diagnosis , Papilloma/virology , Papillomavirus Infections/virology , Precancerous Conditions , Retrospective Studies
3.
Laryngoscope ; 127(9): 2152-2158, 2017 09.
Article in English | MEDLINE | ID: mdl-28635036

ABSTRACT

OBJECTIVES/HYPOTHESIS: Providing high-value healthcare to patients is increasingly becoming an objective for providers including those at multidisciplinary aerodigestive centers. Measuring value has two components: 1) identify relevant health outcomes and 2) determine relevant treatment costs. Via their inherent structure, multidisciplinary care units consolidate care for complex patients. However, their potential impact on decreasing healthcare costs is less clear. The goal of this study was to estimate the potential cost savings of treating patients with laryngeal clefts at multidisciplinary aerodigestive centers. STUDY DESIGN: Retrospective chart review. METHODS: Time-driven activity-based costing was used to estimate the cost of care for patients with laryngeal cleft seen between 2008 and 2013 at the Massachusetts Eye and Ear Infirmary Pediatric Aerodigestive Center. Retrospective chart review was performed to identify clinic utilization by patients as well as patient diet outcomes after treatment. Patients were stratified into neurologically complex and neurologically noncomplex groups. RESULTS: The cost of care for patients requiring surgical intervention was five and three times as expensive of the cost of care for patients not requiring surgery for neurologically noncomplex and complex patients, respectively. Following treatment, 50% and 55% of complex and noncomplex patients returned to normal diet, whereas 83% and 87% of patients experienced improved diets, respectively. Additionally, multidisciplinary team-based care for children with laryngeal clefts potentially achieves 20% to 40% cost savings. CONCLUSIONS: These findings demonstrate how time-driven activity-based costing can be used to estimate and compare patient costs in multidisciplinary aerodigestive centers. LEVEL OF EVIDENCE: 2c. Laryngoscope, 127:2152-2158, 2017.


Subject(s)
Ambulatory Care Facilities/economics , Cost-Benefit Analysis/methods , Delivery of Health Care/economics , Health Care Costs , Patient Care Team/economics , Child , Congenital Abnormalities/economics , Congenital Abnormalities/therapy , Cost Savings , Delivery of Health Care/methods , Humans , Larynx/abnormalities , Massachusetts , Retrospective Studies , Time Factors
4.
JAMA Otolaryngol Head Neck Surg ; 142(9): 851-6, 2016 09 01.
Article in English | MEDLINE | ID: mdl-27356238

ABSTRACT

IMPORTANCE: There is no consensus as to the timing of videofluoroscopic swallow studies (VFSSs) in determining resolving aspiration after laryngeal cleft repair. There is a growing literature on the effect of radiation exposure in children. OBJECTIVE: To modify a previously published best-practice algorithm based on a literature review and our clinical experience to maintain the quality of care provided after successful type 1 laryngeal cleft repair, while reducing the total number of postoperative VFSSs by 10% or greater. DESIGN, SETTING, AND PARTICIPANTS: The previously published algorithm was modified by a multidisciplinary group at a tertiary care academic medical center (Massachusetts Eye and Ear) and was prospectively applied to 31 children who underwent type 1 laryngeal cleft repair from January 1, 2013, to February 28, 2015. MAIN OUTCOMES AND MEASURES: The number of VFSSs obtained in the first 7 months after surgery was compared with the peer-reviewed literature and with a retrospective cohort of 27 patients who underwent type 1 laryngeal cleft repair from January 1, 2008, to December 31, 2012. RESULTS: The study cohort comprised 31 patients. Their ages ranged from 10 to 48 months, with a mean (SD) age of 23.94 (9.93) months, and 19% (6 of 31) were female. The mean (SD) number of postoperative VFSSs per patient before and after implementation of the algorithm was 1.22 (0.42) and 1.03 (0.55), respectively. The use of the algorithm reduced the number of VFSSs by 0.19 (95% CI, -0.07 to 0.45). This reduction in radiation exposure is equivalent to 1.47 chest radiographs per child per course of care. Surgical success was 87% (27 of 31) compared with our group's previously published success rate of 78% (21 of 27) (absolute difference, 0.09; 95% CI, -0.17 to 0.34). CONCLUSIONS AND RELEVANCE: This modified algorithm to help guide decisions on when and how often to obtain VFSSs after type 1 laryngeal cleft repair can limit patients' radiation exposure, while maintaining high surgical success rates.


Subject(s)
Algorithms , Congenital Abnormalities/surgery , Deglutition , Fluoroscopy/statistics & numerical data , Larynx/abnormalities , Radiation Exposure/prevention & control , Respiratory Aspiration/diagnostic imaging , Video Recording , Child, Preschool , Congenital Abnormalities/classification , Congenital Abnormalities/diagnostic imaging , Female , Humans , Infant , Larynx/diagnostic imaging , Larynx/surgery , Male , Pneumonia, Aspiration/etiology , Pneumonia, Aspiration/prevention & control , Postoperative Period , Prospective Studies , Radiation Dosage , Respiratory Aspiration/complications
5.
Otolaryngol Head Neck Surg ; 155(5): 829-836, 2016 11.
Article in English | MEDLINE | ID: mdl-27352894

ABSTRACT

OBJECTIVE: Vocal fold scarring, a condition defined by increased collagen content, is challenging to treat without a method of noninvasively assessing vocal fold structure in vivo. The goal of this study was to observe the effects of vocal fold collagen content on optical coherence tomography imaging to develop a quantifiable marker of disease. STUDY DESIGN: Excised specimen study. SETTING: Massachusetts Eye and Ear Infirmary. SUBJECTS AND METHODS: Porcine vocal folds were injected with collagenase to remove collagen from the lamina propria. Optical coherence tomography imaging was performed preinjection and at 0, 45, 90, and 180 minutes postinjection. Mean pixel intensity (or image brightness) was extracted from images of collagenase- and control-treated hemilarynges. Texture analysis of the lamina propria at each injection site was performed to extract image contrast. Two-factor repeated measure analysis of variance and t tests were used to determine statistical significance. Picrosirius red staining was performed to confirm collagenase activity. RESULTS: Mean pixel intensity was higher at injection sites of collagenase-treated vocal folds than control vocal folds (P < .0001). Fold change in image contrast was significantly increased in collagenase-treated vocal folds than control vocal folds (P = .002). Picrosirius red staining in control specimens revealed collagen fibrils most prominent in the subepithelium and above the thyroarytenoid muscle. Specimens treated with collagenase exhibited a loss of these structures. CONCLUSION: Collagen removal from vocal fold tissue increases image brightness of underlying structures. This inverse relationship may be useful in treating vocal fold scarring in patients.


Subject(s)
Cicatrix/diagnostic imaging , Cicatrix/surgery , Collagen , Tomography, Optical Coherence , Vocal Cords/diagnostic imaging , Vocal Cords/surgery , Animals , Disease Models, Animal , In Vitro Techniques , Swine
7.
Laryngoscope ; 126(6): E218-23, 2016 06.
Article in English | MEDLINE | ID: mdl-26525926

ABSTRACT

OBJECTIVES/HYPOTHESIS: Optical coherence tomography (OCT) is a promising technology to noninvasively assess vocal fold microanatomy. The goal of this study was to develop a methodology using OCT to identify quantifiable markers of vocal fold development. STUDY DESIGN: In vivo study. METHODS: A two-step process was developed to reproducibly image the midmembranous vocal fold edge of 10 patients younger than 2 years and 10 patients between 11 and 16 years of age using OCT. An image analysis algorithm was implemented to extract OCT-derived A-lines for each patient. These A-lines were divided into three zones according to apparent changes in slope. Relative attenuation coefficients, or tissue- and system-dependent parameters that describe the rate at which optical signal decays, were calculated for each zone. RESULTS: Young patients had distinct relative attenuation coefficients in zone 1 (P < .0001), whereas zones 2 and 3 were indistinct (P = .1129). Older patients had distinct relative attenuation coefficients in zones 1, 2, and 3 (P < .0370). Between age groups, relative attenuation coefficients were different in zones 2 and 3 (P < .0001, P = .0315, respectively) and indistinct in zone 1 (P = .1438). CONCLUSIONS: Relative attenuation coefficients can be used as markers of vocal fold development. Differences in relative attenuation coefficients likely represent changes in extracellular matrix structure within the lamina propria and may become useful for guiding treatment of voice disorders in the pediatric population. LEVEL OF EVIDENCE: NA Laryngoscope, 126:E218-E223, 2016.


Subject(s)
Aging/physiology , Algorithms , Tomography, Optical Coherence , Vocal Cords/diagnostic imaging , Adolescent , Child , Extracellular Matrix , Female , Humans , Infant , Male , Mucous Membrane/cytology , Mucous Membrane/diagnostic imaging , Statistics, Nonparametric , Tomography, Optical Coherence/methods , Vocal Cords/cytology , Vocal Cords/growth & development
8.
J Exp Med ; 211(13): 2549-66, 2014 Dec 15.
Article in English | MEDLINE | ID: mdl-25422492

ABSTRACT

DOCK8 mutations result in an inherited combined immunodeficiency characterized by increased susceptibility to skin and other infections. We show that when DOCK8-deficient T and NK cells migrate through confined spaces, they develop cell shape and nuclear deformation abnormalities that do not impair chemotaxis but contribute to a distinct form of catastrophic cell death we term cytothripsis. Such defects arise during lymphocyte migration in collagen-dense tissues when DOCK8, through CDC42 and p21-activated kinase (PAK), is unavailable to coordinate cytoskeletal structures. Cytothripsis of DOCK8-deficient cells prevents the generation of long-lived skin-resident memory CD8 T cells, which in turn impairs control of herpesvirus skin infections. Our results establish that DOCK8-regulated shape integrity of lymphocytes prevents cytothripsis and promotes antiviral immunity in the skin.


Subject(s)
Cell Shape/immunology , Guanine Nucleotide Exchange Factors/metabolism , Immunity , Killer Cells, Natural/pathology , Skin/immunology , Skin/virology , T-Lymphocytes/pathology , Animals , Apoptosis/drug effects , Cattle , Cell Adhesion/drug effects , Cell Nucleus/drug effects , Cell Nucleus/pathology , Cell Shape/drug effects , Chemokine CXCL12/pharmacology , Chemotaxis/drug effects , Collagen/pharmacology , Cytoskeleton/drug effects , Cytoskeleton/metabolism , Female , Guanine Nucleotide Exchange Factors/deficiency , Humans , Immunity/drug effects , Immunologic Memory/drug effects , Killer Cells, Natural/drug effects , Killer Cells, Natural/immunology , Male , Mice , Mice, Inbred C57BL , Signal Transduction/drug effects , Skin/drug effects , Skin/pathology , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , cdc42 GTP-Binding Protein/metabolism , p21-Activated Kinases/metabolism
9.
J Immunol ; 186(1): 222-9, 2011 Jan 01.
Article in English | MEDLINE | ID: mdl-21106845

ABSTRACT

NK cells are innate immune cells that are important in tumor immunity, but also have the ability to modulate the adaptive immune system through cytokine production or direct cell-cell interactions. This study investigates the interaction of NK cells with dendritic cells (DCs) and tumor cells, and the role of specific NK cell-activating receptors in this process. Primary rat NK cells and an NK cell line produced IFN-γ when cocultured with either DCs or the rat hepatoma cell line McA-RH7777 (McA). This NK cell activation by DCs and McA required cell-cell contact and was dependent on distinct NK-activating receptors. Silencing NK cell expression of NKp46 and NKp30 significantly diminished DC- and McA-mediated NK cell IFN-γ production, respectively. NK cells killed immature and mature DCs independently of NKp46, NKp30, and NKG2D; however, cytotoxicity against McA cells was dependent on NKp30 and NKG2D. Thus, we have shown in this study that NKp30 plays dual activating roles in NK-McA tumor interactions by mediating cytokine production and cytotoxicity. More importantly, NK cells are activated by both DCs and hepatoma cells to produce IFN-γ, but require distinct NK cell-activating receptors, NKp46 and NKp30, respectively. Our data suggest that therapeutics could be developed specifically to target NK-DC interactions without compromising NK tumor immunity.


Subject(s)
Cell Communication/immunology , Dendritic Cells/immunology , Lectins, C-Type/physiology , Natural Cytotoxicity Triggering Receptor 1/physiology , Natural Cytotoxicity Triggering Receptor 3/physiology , Neoplasm Proteins/physiology , Receptors, Immunologic/physiology , Trans-Activators/physiology , Adaptive Immunity , Animals , Carcinoma, Hepatocellular/immunology , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Cell Line, Tumor , Cells, Cultured , Coculture Techniques , Cytotoxicity Tests, Immunologic , Dendritic Cells/metabolism , Immunity, Innate , Interferon-gamma/biosynthesis , Liver Neoplasms, Experimental/immunology , Liver Neoplasms, Experimental/metabolism , Liver Neoplasms, Experimental/pathology , NK Cell Lectin-Like Receptor Subfamily K , Rats , Rats, Inbred Lew
SELECTION OF CITATIONS
SEARCH DETAIL
...